Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Dis Esophagus ; 30(1): 1-7, 2017 Jan 01.
Article in English | MEDLINE | ID: mdl-27868307

ABSTRACT

Eosinophilic oesophagitis (EoE) is a chronic immune-mediated esophageal disease, characterized by symptoms related to esophageal dysfunction and histologically by eosinophil predominant inflammation. Current evidence for an adverse impact on quality of life (QoL) is conflicting and there are no data from a UK population regarding QoL. We conducted a prospective cross-sectional observational study using the Short Form-36 Health Survey, Hospital Dysphagia/Odynophagia Questionnaire, and the EoE Adult Quality of Life Questionnaire to assess QoL and severity of dysphagia in EoE patients, compared to age and gender matched healthy control subjects. Data were also collected on comorbidity and medication use. Eighty-eight subjects were recruited (44 patients). Patients had higher rates of antihistamine and topical (swallowed) corticosteroid use. Physical QoL did not differ between patients and controls, although patients did report a statistically significant lower mental QoL, with small absolute magnitude of difference. Patients reported higher dysphagia scores and these were negatively correlated with both physical and mental QoL. Higher rates of dysphagia and medication use in patients may among other things account for lower mental QoL. However, a higher rate of dysphagia in patients is not associated with a reduced physical QoL. Our findings are of clinical value, particularly when a new diagnosis of EoE is made, as clinicians can reassure patients that their general physical health should not be greatly affected by the diagnosis. Moreover, it may also be useful for patients to be aware that EoE may have an impact on their mental health, but this effect is likely to be small. We therefore advocate education and reassurance in this respect for all patients at diagnosis.


Subject(s)
Deglutition Disorders/physiopathology , Eosinophilic Esophagitis/physiopathology , Quality of Life , Activities of Daily Living , Adrenal Cortex Hormones/therapeutic use , Adult , Case-Control Studies , Cross-Sectional Studies , Deglutition Disorders/etiology , Eosinophilic Esophagitis/complications , Eosinophilic Esophagitis/drug therapy , Eosinophilic Esophagitis/psychology , Female , Health Status , Histamine Antagonists/therapeutic use , Humans , Male , Mental Health , Middle Aged , Prospective Studies , Surveys and Questionnaires , United Kingdom
2.
Health Estate ; 54(3): 34-5, 2000 Apr.
Article in English | MEDLINE | ID: mdl-11066997
SELECTION OF CITATIONS
SEARCH DETAIL
...